Omonike Arike Olaleye, Ph.D. is an Associate Professor of Pharmacology in the College of Pharmacy and Health Sciences (COPHS) at Texas Southern University (TSU). She has over 16 years of research experience in drug discovery and development in major pharmaceutical companies and academia. Her formal training in pharmacology was at the Johns Hopkins University School of Medicine (JHU), Baltimore, Maryland. At JHU, she was awarded prestigious pre-doctoral fellowships from both National Aeronautics Space Administration (NASA) and Merck Research Laboratories. Recently, her work has been on the development of new therapeutic agents and formulations for treatment of drug resistant TB and HIV co-infection. She has characterized potential drug candidates for chemotherapy of TB and HIV co-infection. Dr. Olaleye has received several extramural funds and established productive collaborations resulting in awarded grants, publications and patents. In 2016, Dr. Olaleye was awarded the National Institute of Health – UT El Paso BUILDing Scholars Undergraduate Student Mentoring Award of Excellence.